Rapid risk assessment: Zika virus epidemic in the Americas: potential association with microcephaly and Guillain-Barré syndrome - 4th update, 10 December 2015
A Zika virus outbreak in the Americas and the South Pacific is evolving rapidly, and its spread is likely to continue as the vector species Aedes aegypti and Aedes albopictus are widely distributed there.
This is the fourth ECDC rapid risk assessment on Zika virus; the first one was published in February 2014.
Rapid risk assessment: Zika virus disease epidemic. 10th update, 4 April 2017
5 Apr 2017 - This is an updated assessment of the risks associated with the Zika virus epidemic in affected countries, EU Overseas Countries and Territories, and Outermost Regions and in EU Member States within continental Europe.
Rapid risk assessment: Zika virus disease epidemic - 9th update, 28 October 2016
31 Oct 2016 - This update of ECDC’s rapid risk assessment on the Zika epidemic considers the recent epidemiological and scientific information in light of the risk to Europe and European citizens.
Rapid risk assessment: Zika virus disease epidemic, eighth update
31 Aug 2016 - This eighth update assesses the risks associated with the Zika virus epidemic currently affecting countries in the Americas. It provides updated information for those travelling to and returning from affected countries and for EU citizens residing in areas with active transmission. It reviews available information on the association between Zika virus infection and congenital central nervous system malformations, including microcephaly, as well as the association between Zika virus infection and Guillain–Barré syndrome. It also proposes a range of mitigation measures for EU/EEA Member States to consider.